-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
-
Summary
-
Aptose Biosciences Inc. quarterly/annual Nonoperating Income (Expense) history and growth rate from 2017 to 2023.
- Aptose Biosciences Inc. Nonoperating Income (Expense) for the quarter ending June 30, 2024 was $93K, a 71.2% decline year-over-year.
- Aptose Biosciences Inc. Nonoperating Income (Expense) for the twelve months ending June 30, 2024 was $619K, a 55.6% decline year-over-year.
- Aptose Biosciences Inc. annual Nonoperating Income (Expense) for 2023 was $1.15M, a 47.5% increase from 2022.
- Aptose Biosciences Inc. annual Nonoperating Income (Expense) for 2022 was $779K, a 738% increase from 2021.
- Aptose Biosciences Inc. annual Nonoperating Income (Expense) for 2021 was $93K, a 82.5% decline from 2020.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Annual (USD)
Nonoperating Income (Expense), YoY Annual Growth (%)